EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Global Health's enterprise value is ₹316,224 Mil.
Global Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹32,751 Mil. Therefore, Global Health's EV-to-Revenue for today is 9.66.
The historical rank and industry rank for Global Health's EV-to-Revenue or its related term are showing as below:
NSE:MEDANTA'
s EV-to-Revenue Range Over the Past 10 Years
Min: 4.35 Med: 6.56 Max: 12.6
Current: 9.65
During the past 5 years, the highest EV-to-Revenue of Global Health was 12.60. The lowest was 4.35. And the median was 6.56.
NSE:MEDANTA's EV-to-Revenue is ranked worse than 89.31% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 1.845
vs NSE:MEDANTA: 9.65
As of today (2024-05-31), Global Health's stock price is ₹1191.85.
Global Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹121.88. Therefore, Global Health's PS Ratio for today is 9.78.
Global Health EV-to-Revenue Historical Data
The historical data trend for Global Health's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Global Health's EV-to-Revenue
For the Medical Care Facilities subindustry, Global Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Global Health's EV-to-Revenue falls into.
Global Health's current Enterprise Value is ₹316,224 Mil.
Global Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹32,751 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (NSE:MEDANTA) EV-to-Revenue Explanation
Global Health's share price for today is ₹1191.85.
Global Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹121.88.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Global Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:MEDANTA has been successfully added to your 